دواعي استعمال يومان البيومين 20% 1 فيال 50 مل

Uman Albumin 20% (200 g/l): human albumin solution for intravenous infusion, 50 ml vial containing 10 g albumin; hyperoncotic plasma-derived colloid (Kedrion).

• Restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriateIsrael Ministry of Health - Israeli Drug Registry

• Rare mild reactions (flush, urticaria, fever, nausea) usually resolve when the infusion is slowed or stopped; very rarely shock. Post-marketing (frequency not known): hypotension, tremor, dyspnoea, erythema, urticaria, pruritus, chills, pyrexia.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry

• Hypersensitivity to albumin preparations or to any of the excipients.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry

• Suspected allergic or anaphylactic reactions require immediate discontinuation of the infusion; treat shock with standard measures.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry
• Use with caution where hypervolaemia or haemodilution is a special risk: decompensated cardiac insufficiency, hypertension, oesophageal varices, pulmonary oedema, haemorrhagic diathesis, severe anaemia, renal and post-renal anuria.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry
• The 20% solution has about four times the colloid-osmotic effect of plasma; ensure adequate hydration and guard against circulatory overload. It is relatively low in electrolytes - monitor electrolyte status.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry
• Plasma-derived product: transmission of infective agents cannot be totally excluded, although no virus transmissions have been reported with albumin made to European Pharmacopoeia specifications.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry
• Contains up to 157 mg sodium per 50 ml vial.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry

• Other medicinal productsNo specific interactions of human albumin with other medicinal products are known.Israel Ministry of Health - Israeli Drug Registry

• Safety in pregnancy not established in controlled trials, but clinical experience suggests no harmful effects on pregnancy, foetus or neonate; pay particular attention to volume substitution in pregnant patients.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry
• Human albumin is a normal blood constituent; treatment of a nursing mother is not expected to present a risk to the breast-fed infant.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry

• With large replacement volumes, monitor coagulation and haematocrit; give packed red cells if haematocrit falls below 30%; replace other blood constituents as needed.نشرة دولية لنفس المنتج · Israel Ministry of Health - Israeli Drug Registry